{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:01:23Z","timestamp":1757541683777},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1990,1,1]],"date-time":"1990-01-01T00:00:00Z","timestamp":631152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1990]]},"DOI":"10.1007\/bf00689096","type":"journal-article","created":{"date-parts":[[2004,11,29]],"date-time":"2004-11-29T08:41:26Z","timestamp":1101717686000},"page":"125-130","source":"Crossref","is-referenced-by-count":6,"title":["The effect of cimetidine on cyclophosphamide metabolism in rabbits"],"prefix":"10.1007","volume":"27","author":[{"given":"Lowell B.","family":"Anthony","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-cai","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert F.","family":"Struck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth R.","family":"Hande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/bjc.1978.204","volume":"38","author":"DS Alberts","year":"1978","unstructured":"Alberts DS, Peng YM, Chen HS, Struck RF (1978) Effect of phenobarbital on plasma levels of cyclophosphamide and its metabolites in the mouse. Br J Cancer 38: 316","journal-title":"Br J Cancer"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1021\/jf60180a054","volume":"20","author":"JE Bakke","year":"1972","unstructured":"Bakke JE, Feil VJ, Fjelstul CE, Thacker EJ (1972) Metabolism of cyclophosphamide by sheep. J Agric Food Chem 20: 384","journal-title":"J Agric Food Chem"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1021\/jm00370a010","volume":"27","author":"RF Borch","year":"1984","unstructured":"Borch RF, Hoye TR, Swanson TA (1984) In situ preparation and fate ofcis-4-hydroxycyclophosphamide and aldophosphamide. J Med Chem 27: 490","journal-title":"J Med Chem"},{"key":"CR4","first-page":"185","volume":"88","author":"N Brock","year":"1977","unstructured":"Brock N, Hohorst H-J (1977) The problem of specificity and selectivity of alkylating cytostatics: studies onN-2-chloroethylamide-oxazaphosphorines. Z Krebforsch 88: 185","journal-title":"Z Krebforsch"},{"key":"CR5","first-page":"659","volume":"29","author":"N Brock","year":"1979","unstructured":"Brock N, Stekar J, Pohl J, Niemeyer U, Scheffler G (1979) Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide, and sufosfamide. Arzneimittelforschung 29: 659","journal-title":"Arzneimittelforschung"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/0006-2952(79)90222-3","volume":"28","author":"PJ Cox","year":"1979","unstructured":"Cox PJ (1979) Cyclophosphamide cystitis-idendification of acrolein as the causative agent. Biochem Pharmacol 28: 2045","journal-title":"Biochem Pharmacol"},{"key":"CR7","first-page":"3755","volume":"35","author":"PJ Cox","year":"1975","unstructured":"Cox PJ, Phillips BJ, Thomas P (1975) The enzymatic basis of the selective action of cyclophosphamide. Cancer Res 35: 3755","journal-title":"Cancer Res"},{"key":"CR8","first-page":"174","volume":"40","author":"BE Domeyer","year":"1980","unstructured":"Domeyer BE, Sladek NE (1980) Kinetics of cyclophosphamide biotransformation in vivo. Cancer Res 40: 174","journal-title":"Cancer Res"},{"key":"CR9","first-page":"1795","volume":"46","author":"RT Dorr","year":"1986","unstructured":"Dorr RT, Soble MJ, Alberts DS (1986) Interaction of cimetidine but not ranitidine with cyclophosphamide in mice. Cancer Res 46: 1795","journal-title":"Cancer Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM198103193041202","volume":"304","author":"J Feely","year":"1981","unstructured":"Feely J, Wilkinson GR, Wood AJJ (1981) Reduction of liver blood flow and propranolol metabolism by cimetidine. N Engl J Med 304: 692","journal-title":"N Engl J Med"},{"key":"CR11","first-page":"2538","volume":"37","author":"C Fenselau","year":"1977","unstructured":"Fenselau C, Kan MN, Rao SS, Myles A, Friedman OM, Colvin M (1977) Identification of aldophosphamide as a metabolite of cyclophosphamide in vitro and in vivo in humans. Cancer Res 37: 2538","journal-title":"Cancer Res"},{"key":"CR12","first-page":"636","volume":"10","author":"C Fenselau","year":"1982","unstructured":"Fenselau C, Lehman JP, Myles A, Brandt J, Yost GS, Friedman OM, Colvin OM (1982) Iminocyclophosphamide as a chemically reactive metabolite of cyclophosphamide. Drug Metab Dispos 10: 636","journal-title":"Drug Metab Dispos"},{"key":"CR13","first-page":"2761","volume":"32","author":"JY Jao","year":"1972","unstructured":"Jao JY, Jusko WJ, Cohen JL (1972) Phenobarbital effects on cyclophosphamide pharmacokinetics in man. Cancer Res 32: 2761","journal-title":"Cancer Res"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1021\/jm00389a024","volume":"30","author":"CH Kevon","year":"1987","unstructured":"Kevon CH, Kirk MC, Struck RF, Borch RF (1987) Spectroscopic detection of iminocyclophosphamide and its possible role in cyclophosphamide metabolism. J Med Chem 30: 1110","journal-title":"J Med Chem"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265","journal-title":"J Biol Chem"},{"key":"CR16","first-page":"4615","volume":"44","author":"AJ Marinello","year":"1984","unstructured":"Marinello AJ, Bansal SK, Paul B, Koser PL, Love J, Struck RF, Gurtoo HL (1984) Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450. Cancer Res 44: 4615","journal-title":"Cancer Res"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/S0021-9258(20)82245-5","volume":"239","author":"T Omura","year":"1964","unstructured":"Omura T, Sato R (1964) The carbon monoxide-binding pigment of liver microsomes: II. Solubilization, purification and properties. J Biol Chem 239: 2379","journal-title":"J Biol Chem"},{"key":"CR18","first-page":"535","volume":"32","author":"NE Sladek","year":"1972","unstructured":"Sladek NE (1972) Therapeutic efficacy of cyclophosphamide as a function of its metabolism. Cancer Res 32: 535","journal-title":"Cancer Res"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0163-7258(88)90004-6","volume":"37","author":"NE Sladek","year":"1988","unstructured":"Sladek NE (1988) Metabolism of oxazaphosphorines. Pharmacol Ther 37: 301","journal-title":"Pharmacol Ther"},{"key":"CR20","first-page":"2933","volume":"34","author":"RF Struck","year":"1974","unstructured":"Struck RF (1974) Isolation and identification of a stabilized derivative of aldophosphamide, a major metabolite of cyclophosphamide. Cancer Res 34: 2933","journal-title":"Cancer Res"},{"key":"CR21","first-page":"765","volume":"68","author":"RF Struck","year":"1984","unstructured":"Struck RF, Alberts DS (1984) Blood levels of alkylating metabolites of cyclophosphamide in the mouse after IV or oral administration. Cancer Treat Rep 68: 765","journal-title":"Cancer Treat Rep"},{"key":"CR22","first-page":"519","volume":"7","author":"RF Struck","year":"1971","unstructured":"Struck RF, Kirk MC, Mellett LB, Dareer SE, Hill DL (1971) Urinary metabolites of the antitumor agent cyclophosphamide. Mol Pharmacol 7: 519","journal-title":"Mol Pharmacol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1021\/bi00292a019","volume":"22","author":"PP Wang","year":"1983","unstructured":"Wang PP, Beaune P, Kaminsky LS, Dannan GA, Kadlubar FF, Larrey D, Guengerich FP (1983) Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes. Biochemistry 22: 5375","journal-title":"Biochemistry"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00689096.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00689096\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00689096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:30:08Z","timestamp":1625013008000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00689096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1990]]}},"alternative-id":["BF00689096"],"URL":"https:\/\/doi.org\/10.1007\/bf00689096","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990]]}}}